Concepedia

Author

Marta Banach

Jagiellonian UniversityORCID

Also Known As

Giancarlo Comi, M Banach, M. Banach, Marta Banach, Marta D. Banach, Marta Dagmara Banach

122

Publications

1.6K

Citations

20

H-Index

29

Concepts

All Affiliations

Jagiellonian UniversityMedical University of WarsawShirley Ryan AbilityLabMerLion Pharma (Germany)Institute of Psychiatry and Neurology
MB

About

Marta Banach is an author at Jagiellonian University specializing in medicine, neurology, and neuropathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

481

2

Neurology

4

4

268

3

Health Sciences

1

1

22

4

Social Sciences

1

1

21

5

Allergy

1

1

16

Marta Banach

×

21

Publications

1.1K

Citations

18

H-Index

YearCitations

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

James F. Howard, Saskia Bresch, Angela Genge,

The Lancet Neurology

2023

213

Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial

Jean‐Michel Graciès, Allison Brashear, Robert Jech,

The Lancet Neurology

2015

209

SIAXI

Wolfgang H. Jost, Andrzej Friedman, Olaf Michel,

Neurology

2019

114

Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.

Jarosław Sławek, Andrzej Friedman, Anna Potulska‐Chromik,

CNR Solar (Scientific Open-access Literature Archive and Repository) (Consiglio Nazionale delle Ricerche)

2007

93

Efficacy and safety of abobotulinumtoxinA in spastic lower limb

Jean‐Michel Graciès, Alberto Esquenazi, Allison Brashear,

Neurology

2017

90

Efficacy and safety of abobotulinumtoxinA liquid formulation in cervical dystonia: A randomized‐controlled trial

Werner Poewe, Pierre Burbaud, Giovanni Castelnovo,

Movement Disorders

2016

43

Long-term incobotulinumtoxinA treatment for chronic sialorrhea: Efficacy and safety over 64 weeks

Wolfgang H. Jost, Andrzej Friedman, Olaf Michel,

Parkinsonism & Related Disorders

2019

42

Repetitive transcranial magnetic stimulation for the treatment of cognitive impairment in frontotemporal dementia: an open-label pilot study

Jakub Antczak, Katarzyna Kowalska, Aleksandra Klimkowicz‐Mrowiec,

Neuropsychiatric Disease and Treatment

2018

39

Placebo-Controlled Clinical Trial of IncobotulinumtoxinA for Sialorrhea in Children

Steffen Berweck, Marcin Bonikowski, Heakyung Kim,

Neurology

2021

36

Efficacy and Safety of AbobotulinumtoxinA (Dysport) for the Treatment of Hemiparesis in Adults With Upper Limb Spasticity Previously Treated With Botulinum Toxin: Subanalysis From a Phase 3 Randomized Controlled Trial

Christina Marciniak, Peter McAllister, Heather W. Walker,

PM&R

2017

28

Page 1